MetaMask USD
MUSD
Fundamental comparison between MetaMask USD and Noble Dollar (USDN)
MetaMask USD
Noble Dollar (USDN)
Detailed Comparison
| Metric | MetaMask USD | Noble Dollar (USDN) |
|---|---|---|
| Price | $0.999833 | $0.999998 |
| Market Cap | $26.65M | $24.58M |
| 24h Volume | 4.2M | 414.5K |
| Rank | #— | #— |
| Circulating Supply | 26.6M | 24.6M |
| ATH | $1.07 | $1.02 |
MetaMask USD vs Noble Dollar (USDN) — Analysis
MetaMask USD and Noble Dollar (USDN) are two of the most prominent cryptocurrencies in the market. This comparison analyzes both coins based on their current price, market capitalization, trading volume, and — most importantly — their CryptoValue Value Score, which is calculated from 10 fundamental on-chain and market metrics.
Value Score Comparison
With a Value Score of 57.9, MetaMask USD is currently rated as "fair value", while Noble Dollar (USDN) scores 47.1 and is rated "fair value". This means our algorithm considers MetaMask USD the fundamentally stronger investment.
Market Cap & Risk
MetaMask USD has a 1x larger market capitalization than Noble Dollar (USDN). A larger market cap typically means less volatility but also less growth potential. Noble Dollar (USDN) may offer more upside but comes with higher risk.
Price Performance
Over the last 24 hours, MetaMask USD moved -0.01%, while Noble Dollar (USDN) changed -0.00%. Looking at the 7-day window, MetaMask USD is at -0.01% and Noble Dollar (USDN) at -0.00%.
Distance from All-Time High
MetaMask USD currently trades at 94% of its all-time high ($1.07), while Noble Dollar (USDN) sits at 99% of its ATH ($1.02). Coins trading far below their ATH can represent either a buying opportunity or a warning sign — the Value Score helps distinguish between the two.
Conclusion
Based on our fundamental analysis, MetaMask USD (Score: 57.9) currently has a stronger investment case than Noble Dollar (USDN) (Score: 47.1). However, the Value Score is a snapshot that changes daily. We recommend monitoring both coins regularly and conducting your own research before making any investment decisions.
